The American Joint Committee on Cancer (AJCC) staging manual has become the benchmark for classifying patients with cancer, defining prognosis, and determining the best treatment approaches. Many view the primary role of the tumor, lymph node, metastasis (TNM) system as that of a standardized classification system for evaluating cancer at a population level in terms of the extent of disease, both at initial presentation and after surgical treatment, and the overall impact of improvements in cancer treatment. The rapid evolution of knowledge in cancer biology and the discovery and validation of biologic factors that predict cancer outcome and response to treatment with better accuracy have led some cancer experts to question the utility of a TNM-based approach in clinical care at an individualized patient level. In the Eighth Edition of the AJCC Cancer Staging Manual, the goal of including relevant, nonanatomic (including molecular) factors has been foremost, although changes are made only when there is strong evidence for inclusion. The editorial board viewed this iteration as a proactive effort to continue to build the important bridge from a "population-based" to a more "personalized" approach to patient classification, one that forms the conceptual framework and foundation of cancer staging in the era of precision molecular oncology. The AJCC promulgates best staging practices through each new edition in an effort to provide cancer care providers with a powerful, knowledge-based resource for the battle against cancer. In this commentary, the authors highlight the overall organizational and structural changes as well as "what's new" in the Eighth Edition. It is hoped that this information will provide the reader with a better understanding of the rationale behind the aggregate proposed changes and the exciting developments in the upcoming edition. CA Cancer J Clin 2017;67:93-99. © 2017 American Cancer Society.
Keywords: American Joint Committee on Cancer (AJCC); TNM staging; application programing interface; cancer stage; component content management system; electronic health record; precision medicine; prognostic factors; risk assessment models.
© 2017 American Cancer Society.
Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN. Giuliano AE, et al. CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14. CA Cancer J Clin. 2017. PMID: 28294295
Kalli S, Semine A, Cohen S, Naber SP, Makim SS, Bahl M. Kalli S, et al. Radiographics. 2018 Nov-Dec;38(7):1921-1933. doi: 10.1148/rg.2018180056. Epub 2018 Sep 28. Radiographics. 2018. PMID: 30265613 Review.
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Paner GP, et al. Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9. Eur Urol. 2018. PMID: 29325693 Review.
Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform. Gershenwald JE, et al. CA Cancer J Clin. 2017 Nov;67(6):472-492. doi: 10.3322/caac.21409. Epub 2017 Oct 13. CA Cancer J Clin. 2017. PMID: 29028110 Free PMC article.
Olawaiye AB, Baker TP, Washington MK, Mutch DG. Olawaiye AB, et al. CA Cancer J Clin. 2021 Jul;71(4):287-298. doi: 10.3322/caac.21663. Epub 2021 Mar 30. CA Cancer J Clin. 2021. PMID: 33784415
Wang X, Zhao J, Marostica E, Yuan W, Jin J, Zhang J, Li R, Tang H, Wang K, Li Y, Wang F, Peng Y, Zhu J, Zhang J, Jackson CR, Zhang J, Dillon D, Lin NU, Sholl L, Denize T, Meredith D, Ligon KL, Signoretti S, Ogino S, Golden JA, Nasrallah MP, Han X, Yang S, Yu KH. Wang X, et al. Nature. 2024 Sep 4. doi: 10.1038/s41586-024-07894-z. Online ahead of print. Nature. 2024. PMID: 39232164
Leijonmarck W, Mattsson F, Lagergren J. Leijonmarck W, et al. Gastric Cancer. 2024 Sep 4. doi: 10.1007/s10120-024-01545-y. Online ahead of print. Gastric Cancer. 2024. PMID: 39230776
Zhang HY, Aimaiti M, Bai L, Yuan MQ, Zhu CC, Yan JJ, Cai JH, Dong ZY, Zhang ZZ. Zhang HY, et al. Abdom Radiol (NY). 2024 Sep 3. doi: 10.1007/s00261-024-04537-9. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 39225717
Ma J, Tang DB, Tang YQ, Wang DT, Jiang P, Zhang YM. Ma J, et al. World J Gastrointest Surg. 2024 Aug 27;16(8):2528-2537. doi: 10.4240/wjgs.v16.i8.2528. World J Gastrointest Surg. 2024. PMID: 39220070 Free PMC article.
Costantino A, Haughey B, Alamoudi U, Biskup M, Magnuson JS. Costantino A, et al. JAMA Otolaryngol Head Neck Surg. 2024 Aug 29:e242596. doi: 10.1001/jamaoto.2024.2596. Online ahead of print. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39207743